SCHEMBL20867091

SCHEMBL20867091

N=C(NC1N=C(c2ccccc2)c2ccccc2NC1=O)OC(=N)c1nc(-c2ccccc2F)sc1N1CCOCC1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 9/20 0.49
▸ CCKBR P32239 8/20 0.44
▸ CCKAR P32238 7/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20867293 0.94 CBLB (0.51) CBLBCCKBRCCKAR
SCHEMBL20867195 0.94 CBLB (0.51) CBLBCCKBRCCKAR
SCHEMBL24612096 0.93 CCKAR (0.48) CBLBCCKBRCCKAR
SCHEMBL24612115 0.92 CBLB (0.48) CBLBCCKBRCCKAR
SCHEMBL20866810 0.91 CBLB (0.47) CBLBCCKBRCCKAR
SCHEMBL20867292 0.91 CBLB (0.47) CBLBCCKBRCCKAR
SCHEMBL20866881 0.91 CBLB (0.51) CBLBCCKBRCCKAR
SCHEMBL20866814 0.91 CBLB (0.51) CBLBCCKBRCCKAR
SCHEMBL20866687 0.90 CBLB (0.45) CBLBCCKBRCCKAR
SCHEMBL20866787 0.90 CBLB (0.51) CBLBCCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback